DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Hasslacher C, Koselj M, Gall M, Sieber J, Leyck Dieken M.
Safety and efficacy of repaglinide in 281 type 2 diabetic patients with or without renal impairment.
Diabetes 2001; 50 (Suppl 2): A116-A116
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.